Automating iPSC culture: scalable workflows

Tuesday 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST

Sponsor

Automating iPSC culture: scalable workflows

Discover how closed, automated systems are reshaping iPSC culture—delivering greater efficiency, consistency, and scalability for advanced cell therapy and research applications.

In this session, experts from Terumo Blood and Cell Technologies and Karolinska Institutet will share practical insights into optimizing 2D iPSC culture workflows, performing full cellular analysis in hollow fiber bioreactors, and generating spheroids in a closed, automated environment. The discussion also addresses common challenges in automation and how to overcome them to streamline your processes.

You will hear real-world case studies from a collaboration with Karolinska and see data that demonstrate measurable gains in efficiency and reproducibility. Plus, market insights will help you stay ahead of emerging trends in iPSC and spheroid culture.

This webinar offers actionable strategies to optimize your workflows and scale with confidence.

Watch this webinar to:

Explore closed, automated processes that reduce manual handling and improve reproducibility.
Gain insights into full cellular profiling of iPSCs cultured in scalable, closed systems.

Sophia Borate

Post Doctoral Researcher, Cell and Gene Therapy Group at Department of Medicine, Karolinska Institutet, Sweden

Sophia joined Evren Alici’s lab at Karolinska Institutet, Stockholm, Sweden in 2022 as a post-doctoral researcher and her current focus is to expand iPSC and also to differentiate them to Natural Killer (NK) cells in a GMP-compliant process. Aiming to streamline the process while scaling up to obtain enough cell numbers that can be clinically translatable. She obtained her PhD in Biotechnology from India where she was developing iPSCs lines from patients with haematological malignancies and healthy donors, trying to further differentiate them to haematopoietic and neural lineages and also looking into strategies to efficiently cryopreserve them. After her PhD, she also worked for a CRO for 1.5 years to develop 3D-human skin grafts in-vitro. She has more than a decade of experience working with generating, characterizing and differentiating induced pluripotent stem cells (iPSCs) and other human primary stem cells like hematopoietic stem cells (HSCs) and mesenchymal stem cells (MSCs).

Nathan Frank

Senior Research Scientist at Terumo Blood and Cell Technologies

Nate has more than a decade of experience optimizing parameters for cell and gene therapy production and scale-up. He has specialized expertise in hollow fiber bioreactor process development for a range of cell types aimed at various applications in regenerative medicine and immunotherapy. He is a two-time National Science Foundation fellow and has a passion for teaching and communicating science to a wide range of audiences from established professionals to middle and high school students who are just beginning their scientific journey.

You have registered for this webinar